NCT00624962 Early Enteral Tube Feedings in Children Receiving Chemo for AML/MDS & High Risk Solid Tumors Status WITHDRAWN Phase NA
NCT00544336 Family Quality of Life Among Families With a Member Who is a Cancer Patient Status COMPLETED Phase N/A
NCT00512798 Bortezomib and Temozolomide in Treating Patients With Advanced Refractory Solid Tumors or Melanoma Status TERMINATED Phase PHASE1/PHASE2
NCT00499668 Aprepitant or Ondansetron in Treating Nausea and Vomiting Caused By Opioids in Patients With Cancer Status WITHDRAWN Phase NA
NCT00483457 Effects of Epidermal Growth Factor Receptor Inhibitor Therapy in the Skin of Cancer Patients Status COMPLETED Phase N/A
NCT00479128 Bortezomib With Gemcitabine/Doxorubicin in Patients With Urothelial Cancer and Other Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT00470405 Pemetrexed and Oxaliplatin in Treating Patients With Metastatic Solid Tumors or Lymphoma Status COMPLETED Phase PHASE1
NCT00469937 Ph I Study of Lithium During Whole Brain Radiotherapy For Patients With Brain Metastases Status TERMINATED Phase PHASE1
NCT00413075 Study of Oral PXD101 in Patients With Advanced Solid Tumors or Lymphoma Status COMPLETED Phase PHASE1
NCT00354523 Imatinib in Combination With Dacarbazine and Capecitabine in Medullary Thyroid Carcinoma Status TERMINATED Phase PHASE1/PHASE2
NCT00333502 Study of CRLX101 (NLG207) in the Treatment of Advanced Solid Tumors Status COMPLETED Phase PHASE1/PHASE2
NCT00300001 Home-Based Symptom Monitoring: Its Impact on Cancer Care Team Behaviors and Patient Outcomes Status UNKNOWN Phase N/A
NCT00251407 Taxotere, Cisplatin, and CPT-11 in Advanced Solid Tumor Malignancies Status COMPLETED Phase PHASE1
NCT00215501 Capecitabine or 5-Fluorouracil in Combination With Irinotecan and Cisplatin in Patients With Solid Tumor Malignancies Status COMPLETED Phase PHASE1
NCT00052273 LY317615 Plus Capecitabine in Treating Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1